Chung-Chieh Hung | Healthcare Data Analysis | Best Researcher Award

Dr. Chung-Chieh Hung | Healthcare Data Analysis | Best Researcher Award

Doctorate at Chung Shan Medical University Hospital, Taiwan

πŸ‘¨β€πŸŽ“ Profile

🩺 Current Position

Dr. Chung-Chieh Hung is the Chief of the Subdivision of Prevention of Addictive Diseases at the Department of Psychiatry, China Medical University Hospital, a role he has held since 2020. In this capacity, he leads efforts to address addiction-related disorders and improve treatment strategies.

🧠 Specialties

Dr. Hung specializes in various areas of psychiatry, including General Psychiatry, where he treats conditions such as anxiety disorders, sleep disorders, depression, bipolar disorder, schizophrenia, and dementia. His expertise also extends to Forensic Psychiatry, where he handles cases related to domestic violence and sexual offenders. Additionally, he is well-versed in Addiction Medicine and Judicial Psychiatric Evaluation, providing comprehensive assessments and treatments for addiction and legal cases.

πŸŽ“ Education

Dr. Hung obtained his Bachelor of Medicine from Chang Gung University. He furthered his education with a Master of Medical Science and a Doctor of Medical Science from China Medical University. Additionally, he holds a Master of Law from National Chung Hsing University and is currently pursuing a PhD in Law at National Chengchi University.

πŸ₯ Professional Experience

Dr. Hung began his career as a Resident in Pediatric Internal Medicine at Linkou Chang Gung Memorial Hospital. He then served as a Chief Resident and Research Physician in the Department of Psychiatry at China Medical University Hospital before becoming an Attending Psychiatrist. From 2020 to 2023, he was the Director of the Division of Addiction Prevention.

πŸ“° Academic Research and Publications

Dr. Hung has made significant contributions to psychiatry through his publications in renowned journals like JAMA Psychiatry and Frontiers in Bioengineering and Biotechnology. His research includes studies on Betel-Quid Use Disorder and the effects of antidepressants on betel-quid use, among others.

🌍 Oral Presentations & Posters

He has presented his research at various prestigious conferences, including the World Psychiatry Association Regional Meeting and international symposia on psychiatry and addiction.

🧩 Research Projects

Dr. Hung has led several research projects funded by the Ministry of Health and Welfare, focusing on problematic alcohol use, addiction treatment services, and methadone treatment quality improvement.

πŸ›οΈ Professional Roles in Government and Professional Organizations

He serves on the Domestic Violence Pre-Trial Assessment Panel for the Taichung City Health Bureau and is a Medical Dispute Initial Assessment Personnel for the Medical Quality Advancement Association. He is also an expert on sexual assault prevention laws for the Ministry of Health and Welfare and an external inspector for the Ministry of Justice’s Correctional Services.

βš–οΈ Forensic Psychiatry Evaluations

Dr. Hung has provided expert forensic psychiatric evaluations in various high-profile legal cases, including those involving sexual autonomy, violent crimes, and drug-related offenses.

🌟 Victim Assessments

He has also conducted assessments for victims of domestic violence and sexual crimes, offering crucial insights into victim credibility and trauma evaluation.

πŸ“– Publications

Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid
    • Authors: Chung-Chieh Hung, Ying-Chin Ko, Chia-Min Chung
    • Journal: Current Issues in Molecular Biology
    • Year: 2024
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
    • Authors: Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane
    • Journal: International Journal of Molecular Sciences
    • Year: 2021
Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry
    • Authors: Chieh-Hsin Lin, Hung Su, Chung-Chieh Hung, Hsien-Yuan Lane, Jentaie Shiea
    • Journal: Molecules
    • Year: 2021
An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
    • Authors: Eugene Lin, Chieh-Hsin Lin, Chung-Chieh Hung, Hsien-Yuan Lane
    • Journal: Frontiers in Bioengineering and Biotechnology
    • Year: 2020
Effect of Antidepressants for Cessation Therapy in Betel-Quid Use Disorder: A Randomised, Double-Blind, Placebo-Controlled Trial
    • Authors: Chung-Chieh Hung, Chien-Hung Lee, Albert Min-Shan Ko, Chi-Pin Lee, Ying-Chin Ko
    • Journal: Epidemiology and Psychiatric Sciences
    • Year: 2020
Antidepressant-Induced Reduction in Betel-Quid Use in Patients with Depression: A Pioneer Clinical Study
    • Authors: Chung-Chieh Hung, Chien-Hung Lee, Chia-Min Chung, Hsien-Yuan Lane, Ying-Chin Ko
    • Journal: Medicine (Baltimore)
    • Year: 2020
Variants in FAT1 and COL9A1 Genes in Male Population with or without Substance Use to Assess the Risk Factors for Oral Malignancy
    • Authors: Chia-Min Chung, Chung-Chieh Hung, Chieh-Hsin Lin, Kuan-Tsa Yeh, Ying-Chin Ko
    • Journal: PLoS ONE
    • Year: 2019
Association of DSM-5 Betel-Quid Use Disorder with Oral Potentially Malignant Disorder in 6 Betel-Quid-Endemic Asian Populations
    • Authors: Chien-Hung Lee, Albert Min-Shan Ko, Frances M Yang, Chung-Chieh Hung, Saman Warnakulasuriya, Salah Osman Ibrahim, Rosnah Binti Zain, Ying-Chin Ko
    • Journal: JAMA Psychiatry
    • Year: 2018
Hypothyroidism May Exacerbate Valproate-Related Hyperammonemic Delirium
    • Authors: Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane
    • Journal: BioMedicine (Netherlands)
    • Year: 2016

Keeley Rigby | Healthcare Data Analysis | Best Researcher Award

Mrs. Keeley Rigby, Healthcare Data Analysis, Best Researcher Award

Mrs. Keeley Rigby at Sheffield Hallam University, United Kingdom

Professional Profile

Scopus Profile
Orcid Profile

🌟Summary

Keeley Louise Rigby (Rosbottom) is a seasoned Therapeutic Radiographer with a distinguished career in radiotherapy and oncology. She currently serves as the Course Leader for the Therapeutic Radiography Degree Apprenticeship and Senior Lecturer in Radiotherapy & Oncology at a prestigious institution. Keeley is recognized for her expertise in teaching and research, particularly in areas like sarcomas, digestive systems, and endocrine systems. Her commitment to enhancing patient care and survivorship is evident through her leadership in projects like the CELEBRATE study on the impact of the end of treatment bell in radiotherapy.

πŸŽ“Education

Keeley Louise Rigby (Rosbottom) holds a Master of Science degree in Radiotherapy & Oncology in Practice, earned from Sheffield Hallam University in September 2015. Her academic journey also includes a Postgraduate Certificate in Learning and Teaching in Higher Education, completed in April 2014, and a Postgraduate Diploma in Radiotherapy & Oncology in Practice with Distinction, attained from the same institution in September 2008. She initially pursued her passion for medical sciences, earning a Bachelor of Science with Honors from the University of Leeds in June 2005. Keeley’s educational achievements have equipped her with a solid foundation to excel in her roles as Course Leader and Senior Lecturer in Radiotherapy & Oncology, where she continues to integrate cutting-edge research and teaching methodologies into her practice.

πŸ’Ό Professional Experience

Keeley has held progressive roles in radiotherapy, starting as a Radiotherapy Practitioner Radiographer and advancing to her current positions. She has extensive experience in clinical practice, education, and research, contributing significantly to the field through innovative teaching methods and scholarly activities.

πŸ”¬ Research Interests

Her research interests encompass improving patient quality of life, exploring innovative radiotherapy techniques, and advancing education in therapeutic radiography. Keeley has actively participated in projects like the SuPPORT 4 All and CELEBRATE studies, focusing on enhancing patient outcomes and experiences during and after radiotherapy treatment.

πŸ“– Publication Top Noted